Phase 3 ePHex Study: OxThera Reports Results
Sid Martin Biotech alum OxThera AB, a biopharma company dedicated to improving the lives of people with Primary Hyperoxaluria (PH), announces results of its pivotal Phase 3 study.
Tag
primary hyperoxaluria
Tech Licensing: (352) 392-8929
The Hub: (352) 294-0885
747 SW 2nd Avenue
Gainesville, FL 32601
Sid Martin Biotech: (386) 462-0880
12085 Research Drive
Alachua, FL 32615